Fig 1.
South African National Department of Health policy on eligibility for decentralized drug-resistant TB care.
Fig 2.
Description of cohort.
Table 1.
Descriptive characteristics at initiation of second-line TB treatment of RR-TB patients.
Table 2.
TB disease of RR-TB patients at enrolment.
Table 3.
TB disease of RR-TB patients at enrolment^, laboratory results.
Table 4.
Interim (6-month) RR-TB treatment outcomes.
Table 5.
Relative risk* and 95% confidence intervals of dying or being lost from treatment.